Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03021161 |
Date of registration:
|
11/01/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers
prob&asthma |
Scientific title:
|
The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers: A Randomized Controlled Trial. |
Date of first enrolment:
|
January 2017 |
Target sample size:
|
200 |
Recruitment status: |
Not yet recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03021161 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Brazil
| | | | | | | |
Contacts
|
Name:
|
Elcio O Vianna, MD, PHD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of S. Paulo Medical School of Rib. Preto |
|
Name:
|
Elcio O Vianna, MD, PHD |
Address:
|
|
Telephone:
|
55-16-3602-2706 |
Email:
|
evianna@fmrp.usp.br |
Affiliation:
|
|
|
Name:
|
Elcio O Vianna, MD, PHD |
Address:
|
|
Telephone:
|
55-16-36022706 |
Email:
|
evianna@fmrp.usp.br |
Affiliation:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Older than 18 years, both sexes, ability to read, understand and to decide on protocol
consenting.
- Participants should be healthy
- Animal handling for research purposes as part of regular activities as a worker or
student.
- Planning to continue this activity for the next 2 years.
Exclusion Criteria:
- Previous laboratory animal handling for 15 days or longer. This exposure may have
sensitized or selected people that are not susceptible to sensitizations.
- Sensitization to any laboratory animal (rat, mouse, hamster, guinea pig or rabbit).
- Allergic diseases that interfere with the evaluation of study variables.
- Using immunosuppressive drugs (ex: methotrexate, cyclosporine, leflunomide) or
corticosteroids in immunosuppressive doses (e.g.: prednisone doses of 1.0 mg/kg/day or
more).
- Cancer or treatment of neoplasia.
- Having diseases that cause immunosuppression such as diabetes, AIDS, renal failure,
heart failure or other organ failure.
- Pregnancy, breastfeeding, or not willing to take necessary precautions to avoid a
pregnancy during the study.
- Use of other probiotic products during the study.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Asthma Occupational
|
Intervention(s)
|
Other: Placebo Oral Capsule
|
Drug: Probiotic Formula
|
Primary Outcome(s)
|
detection the reduction of sensitization in workers exposed to laboratory animal
[Time Frame: two years]
|
Secondary Outcome(s)
|
Assessment of symptoms
[Time Frame: two years]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|